New funding for a dire need: Pancreas cancer early detection

With a $250,000 award from the Pancreatic Cancer Action Network, researchers will seek to validate biomarkers able to detect pancreas cancer months or years before patients experience overt symptoms...

New insight into the anti-cancer effect of aspirin

For reasons that remain uncertain, people who take aspirin on a regular basis have a reduced risk of colorectal cancer and certain other malignancies. Now researchers have identified a...

Wanted: Patients’ perspectives on cancer research

Five years ago, Betty Booher’s husband was diagnosed with primary cancers in the colon and the pancreas and died at age 57. In the aftermath, she says, “It was important to me to find a way to...

Finding lessons in a failed pancreatic cancer clinical trial

Nearly a third of people diagnosed with pancreatic adenocarcinoma have locally advanced tumors that cannot be removed by surgery. A longstanding and critical question for these patients is...

Advancing a potential blood test for pancreatic cancer

Immunovia’s "IMMray" technology uses an antibody microarray to detect the protein signature of pancreatic cancer in blood samples. The Swedish biotech firm Immunovia reached another milestone...